Company overview
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing TLSI with another company.
| Daily close (USD) | $4.13 |
| Market capitalization (USD) | $254,303,098 |
| Price / earnings (TTM) | Not reported |
| Price / book | 38.82 |
No matching rows. Clear the filter to see all records.
Read TLSI's valuation metrics
Company size
TriSalus Life Sciences, Inc. Common Stock's recorded market capitalization is $254,303,098. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TLSI's recorded price-to-book ratio is 38.82. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research TriSalus Life Sciences, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about TLSI. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TLSI's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.